Expression of Placental Lipid Transporters in Pregnancies Complicated by Gestational and Type 1 Diabetes Mellitus

Paweł Jan Stanirowski,Mateusz Wątroba,Michał Pyzlak,Jarosław Wejman,Dariusz Szukiewicz
DOI: https://doi.org/10.3390/ijms25063559
IF: 5.6
2024-03-22
International Journal of Molecular Sciences
Abstract:The objective of the study was to assess the expression of proteins responsible for placental lipid transport in term pregnancies complicated by well-controlled gestational (GDM) and type 1 diabetes mellitus (PGDM). A total of 80 placental samples were obtained from patients diagnosed with PGDM (n = 20), GDM treated with diet (GDMG1, n = 20), GDM treated with diet and insulin (GDMG2, n = 20), and a non-diabetic control group (n = 20). Umbilical and uterine artery blood flows were assessed by means of ultrasound in the period prior to delivery and computer-assisted quantitative morphometry of immunostained placental sections was performed to determine the expression of selected proteins. The morphometric analysis performed for the vascular density-matched placental samples demonstrated a significant increase in the expression of fatty acid translocase (CD36), fatty acid binding proteins (FABP1, FABP4 and FABP5), as well as a decrease in the expression of endothelial lipase (EL) and fatty acid transport protein (FATP4) in the PGDM-complicated pregnancies as compared to the GDMG1 and control groups (p < 0.05). No significant differences with regard to the placental expression of lipoprotein lipase (LPL) and FATP6 protein between GDM/PGDM and non-diabetic patients were noted. Maternal pre-pregnancy weight, body mass index, placental weight as well as the expression of LPL and FABP4 were selected by the linear regression model as the strongest contributors to the fetal birth weight. To conclude, in placentas derived from pregnancies complicated by well-controlled PGDM, the expression of several lipid transporters, including EL, CD36, FATP4, FABP1, FABP4 and FABP5, is altered. Nonetheless, only LPL and FABP4 were significant predictors of the fetal birth weight.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
This paper mainly discusses the changes in the expression of placental lipid transport proteins in pregnant women with gestational diabetes mellitus (GDM) and type 1 diabetes mellitus (PGDM), and compares them with normal pregnancies. The study found that compared to the GDM and control groups, the expression of fatty acid translocase (CD36), fatty acid binding proteins (FABP1, FABP4, and FABP5) in the placenta of PGDM patients increased, while the expression of endothelial lipase (EL) and fatty acid transport protein 4 (FATP4) decreased. Although there was no significant difference in the expression of LPL and FABP4 among different diabetes groups and non-diabetic patients, they were strong predictors of birth weight. The paper also pointed out that these changes may affect fetal fat accumulation and growth, such as leading to macrosomia. The results of the study emphasize the potential impact of changes in placental lipid transport processes in a diabetic environment on fetal development.